We are monitoring the impact of COVID-19 on Europe Wearable Cardioverter Defibrillator Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4409
Share on
Share on

Europe Wearable Cardioverter Defibrillator Market Research Report – Segmented By Conditions, End User and Country (the United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4409
Pages: 136

The size of the Wearable Cardioverter Defibrillator Market in Europe is predicted to grow at a robust CAGR from 2020 to 2025.

Wearable cardioverter defibrillator is a gadget that is non-invasive it is utilized to prevent sudden heart attack. It has two parts: A light weight jacket which is worn under regular clothes and a small mobile unit which includes recorder and generator. Sudden heart attack occurs when the heart's electrical system malfunctions. It directs the heart to relax and contract. Those conditions where there is abnormal rhythm in the ventricles of the heart is known as Ventricular Fibrillation. When VF occurs, a WCD sends an electrical current to the heart that is used to revive a normal heart rhythm. Defibrillators are used for the treatment of life-threatening ventricular fibrillation, heart dysrhythmias, and ventricular tachycardia.

Rising prevalence of diseases, increasing geriatric population, growing number of training and awareness among the population base and, technological advancements are the primary drivers of the market.On the other hand, factors like problems related to the use of wearable cardioverter defibrillator devices, inadequate knowledge regarding sudden cardiac arrest, and the wearable cardioverter defibrillator does not monitor atrial arrhythmias thus this hinders the growth of the market.

Europe Wearable Cardioverter Defibrillator Market Segmentation by Conditions and by End User. By Conditions it is segmented into Peripartum Cardiomyopathy, Congenital Heart Disease, and Inherited Arrhythmias. By End User the market is segmented into Hospitals, Home Care Settings, and Cardiology Clinics.Europe Wearable Cardioverter Defibrillator Market geographical segmentation by UK, Spain, Germany, France and others. Europe is the second largest market.

The major Europe Wearable Cardioverter Defibrillator Market leaders are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan).

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Conditions                                                                  

                                5.1.1 Introduction                                                           

                                5.1.2 Peripartum Cardiomyopathy                                                           

                                5.1.3 Congenital Heart Disease                                                  

                                5.1.4 Inherited Arrhythmias                                                       

                                5.1.5  Y-o-Y Growth Analysis, By Conditions                                                         

                                5.1.6  Market Attractiveness Analysis, By Conditions                                                       

                                5.1.7  Market Share Analysis, By Conditions                                                        

                5.2 End User                                                                      

                                5.2.1 Introduction                                                           

                                5.2.2 Hospitals                                                  

                                5.2.3 Home Care Settings                                                            

                                5.2.4 Cardiology Clinics                                                  

                                5.2.5 Y-o-Y Growth Analysis, By End User                                                             

                                5.2.6 Market Attractiveness Analysis, By End User                                                           

                                5.2.7 Market Share Analysis, By End User                                                             

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Conditions                                     

                                                6.1.3.3 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Conditions                                     

                                                6.1.4.3 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Conditions                                     

                                                6.1.5.3 By End User                                        

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 ZOLL Medical Corporation                                                                    

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic PLC (Ireland)                                                                        

                8.3 St. Jude Medical                                                                       

                8.4 Boston Scientific Corporation (U.S.)                                                                 

                8.5 BIOTRONIK SE & Co. KG (Germany)                                                                 

                8.6 LivaNova PLC (U.K.)                                                                

                8.7 Koninklijke Philips N.V. (Netherlands)                                                                            

                8.8 Cardiac Science Corporation (U.S.)                                                                   

                8.9 Physio-Control                                                                          

                8.10 Nihon Kohden Corporation (Japan)                                                                               

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Market Outlook and Investment Opportunities                                                                                         

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Conditions and by End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  2. Europe Peripartum Cardiomyopathy Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Congenital Heart Disease Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Inherited Arrhythmias Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)
  6. Europe Hospital Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Home Care Settings Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Cardiology Clinics Market, By Region, From 2020 to 2025 (USD Million)
  9. U.K. Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  10. U.K. Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)
  11. Germany Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  12. Germany Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)
  13. France Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  14. France Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)
  15. Italy Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  16. Italy Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)
  17. Spain Wearable Cardioverter Defibrillator Market, By Conditions, From 2020 to 2025 (USD Million)
  18. Spain Wearable Cardioverter Defibrillator Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample